glp 1 compounding restrictions FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Compounding Crackdown | Double-Helix

10.1126/scitranslmed.aaz5677 32 Demers-LamarcheJ.GuillebaudG.TliliM.TodkarK.BelangerN.GrondinM.et al (2016)

For those who are overweight, there is a lot of evidence to suggest that losing weight may help lower your AHI score

Concerns are escalating about the risk of gastroparesis, a condition commonly known as stomach paralysis, which is often associated with these medications

And when protein slips, muscle loss accelerates

adults now say they are currently taking a GLP-1 medication, and these drugs have grown fast enough to reshape how everyone talks about weight management not just in doctors offices but among our friends, family and even coworkers

CMS will be critical of plans efforts to ensure members have access